The authors concluded that the efficacy and safety of electroconvulsive therapy in patients with bipolar disorder had been poorly investigated and the evidence had methodological limitations. However, high response rates were observed in patients who received electroconvulsive therapy. Given the limited quality of the evidence presented and the significant heterogeneity between trials, the authors' concluding statement seems appropriate.
Included studies were of patients with bipolar mania, bipolar depression, mixed states or compared bipolar versus unipolar depression or manic versus bipolar depressed patients. Some patients were medication resistant. Intervention patients received ECT with or without antipsychotics or chlorpromazine. Controls included simulated ECT plus chlorpromazine or antipsychotics or an antidepressant, lithium with or without haloperidol, other medications (not specified) Two reviewers screened studies for inclusion.
Assessment of study quality
The authors did not state that they assessed trial quality, although blinding was reported for controlled/comparative trials.
Data extraction
The authors did not state how many reviewers performed the data extraction.
Methods of synthesis
Data were presented as a narrative synthesis, grouped by type of bipolar disorder.
Results of the review
Fifty-one trials were included in the review.
ECT in bipolar mania: There were 28 clinical trials (1,651 participants). The three controlled/comparative prospective trials (one double blind) showed that ECT with or without chlorpromazine was more effective than simulated ECT or lithium. Of the six controlled/comparative retrospective trials, two reported significant benefit from ECT compared to no treatment or lithium. Overall, the non-comparative studies showed significant improvements with ECT.
